Literature DB >> 23361194

Susceptibility to viral infections in chronic obstructive pulmonary disease: role of epithelial cells.

Uma S Sajjan1.   

Abstract

PURPOSE OF REVIEW: The aim is to understand how airway epithelial cells with compromised innate defense mechanisms enhance susceptibility to respiratory virus infections in chronic obstructive pulmonary disease (COPD). RECENT
FINDINGS: Exacerbations associated with respiratory viruses are more severe and increase disease severity in COPD. Airway epithelial cells cultured from COPD patients show excessive innate immune response to viral infection and higher viral load compared with normal cells.
SUMMARY: Airway epithelial cells are the first line of defense in the lung and are equipped with several lines of innate defense mechanisms to fight against invading pathogens including viruses. Under normal conditions, mucociliary and barrier functions of airway epithelial cells prevent virus binding and entry into the cells. Virus-infected airway epithelial cells also express various cytokines, which recruit and activate innate and adaptive immune cells ultimately controlling the infection and tissue damage. In COPD however, compromised mucociliary and barrier functions may increase virus binding and allow virus entry into airway epithelial cells. Virus-infected COPD airway epithelial cells also show disproportionate cytokine expression leading to inappropriate recruitment and activation of innate and adaptive immune cells. COPD airway epithelial cells also show defective antiviral responses. Such defects in innate defense mechanisms may increase susceptibility to viral infections and disease severity in COPD.

Entities:  

Mesh:

Year:  2013        PMID: 23361194     DOI: 10.1097/MCP.0b013e32835cef10

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  17 in total

1.  Clinical relevance of multiple respiratory virus detection in adult patients with acute respiratory illness.

Authors:  Seong-Ho Choi; Jin-Won Chung; Hye Ryoun Kim
Journal:  J Clin Microbiol       Date:  2015-01-28       Impact factor: 5.948

Review 2.  Innate immunity and chronic obstructive pulmonary disease: a mini-review.

Authors:  Renat Shaykhiev; Ronald G Crystal
Journal:  Gerontology       Date:  2013-09-03       Impact factor: 5.140

Review 3.  Innate receptors and cellular defense against pulmonary infections.

Authors:  Jessica L Werner; Chad Steele
Journal:  J Immunol       Date:  2014-10-15       Impact factor: 5.422

4.  Future Research Directions in Pneumonia. NHLBI Working Group Report.

Authors:  Charles S Dela Cruz; Richard G Wunderink; David C Christiani; Stephania A Cormier; Kristina Crothers; Claire M Doerschuk; Scott E Evans; Daniel R Goldstein; Purvesh Khatri; Lester Kobzik; Jay K Kolls; Bruce D Levy; Mark L Metersky; Michael S Niederman; Roomi Nusrat; Carlos J Orihuela; Paula Peyrani; Alice S Prince; Julio A Ramírez; Karen M Ridge; Sanjay Sethi; Benjamin T Suratt; Jacob I Sznajder; Ephraim L Tsalik; Allan J Walkey; Sachin Yende; Neil R Aggarwal; Elisabet V Caler; Joseph P Mizgerd
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

5.  Vaccine Effectiveness Against Influenza-Associated Lower Respiratory Tract Infections in Hospitalized Adults, Louisville, Kentucky, 2010-2013.

Authors:  Eric J Chow; Melissa A Rolfes; Ruth L Carrico; Stephen Furmanek; Julio A Ramirez; Jill M Ferdinands; Alicia M Fry; Manish M Patel
Journal:  Open Forum Infect Dis       Date:  2020-06-30       Impact factor: 3.835

6.  Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection.

Authors:  Robert F Foronjy; Abdoulaye J Dabo; Neville Cummins; Patrick Geraghty
Journal:  BMC Immunol       Date:  2014-10-03       Impact factor: 3.615

7.  Colds as predictors of the onset and severity of COPD exacerbations.

Authors:  Neil W Johnston; Marita Olsson; Staffan Edsbäcker; Maria Gerhardsson de Verdier; Per Gustafson; Christopher McCrae; Peter V Coyle; R Andrew McIvor
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-03-10

Review 8.  Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis.

Authors:  Ralph A Tripp
Journal:  Immune Netw       Date:  2013-10-26       Impact factor: 6.303

9.  Respiratory syncytial virus infections enhance cigarette smoke induced COPD in mice.

Authors:  Robert F Foronjy; Abdoulaye J Dabo; Clifford C Taggart; Sinead Weldon; Patrick Geraghty
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Diminished COX-2/PGE2-Mediated Antiviral Response Due to Impaired NOX/MAPK Signaling in G6PD-Knockdown Lung Epithelial Cells.

Authors:  Hsin-Ru Lin; Yi-Hsuan Wu; Wei-Chen Yen; Chuen-Mao Yang; Daniel Tsun-Yee Chiu
Journal:  PLoS One       Date:  2016-04-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.